期刊文献+

口服布洛芬治疗动脉导管未闭早产儿的疗效及安全性评价 被引量:4

Evaluation of Efficacy and Safety of Oral Ibuprofen in the Treatment of Preterm Infant with Patent Ductus Arteriosus
下载PDF
导出
摘要 目的:观察口服制剂布洛芬对早产儿动脉导管未闭(PDA)的治疗疗效和不良反应。方法:选择符合入选标准的早产儿PDA 106例,给予口服布洛芬混悬滴剂,每24小时给药一次,剂量分别为(10-5-5)mg/kg。用药期间和结束后监测PDA关闭情况、循环功能、肾功能、出凝血功能和颅内出血发生情况。结果:(1)经治疗99例(99/106,93.4%)PDA关闭。(2)疗效与胎龄有关,胎龄≥34周疗效为96.4%(54/56),优于胎龄<34周的疗效90%(45/50),差异有统计学意义(P<0.05)。出生体质量≥2000 g疗效与出生体质量<2000 g相当,分别为94.2%(49/52)和92.6%(50/54),差异无统计学意义(P>0.05)。(3)不良反应表现为一过性少尿(46.2%),肌酐和尿素水平正常。未发现血小板减少。早产儿喂养不耐受发生率为29.2%,程度较轻,未出现坏死性小肠结肠炎。未发现颅内出血加重。结论:口服布洛芬可以关闭早产儿动脉导管未闭,近期不良反应发生率较低。但尚需观察其远期不良反应,以评价其安全性。 Objective: To study efficacy and safety of oral ibuprofen ( Motrin suspension ) in the treatment of preterm infant with patent ductus arteriosus ( PDA ) . Method: A total of 106 preterm infants with PDA were included 3 to 18 days after birth. The patients were orally administered ibuprofen, and the doses were 10-5-5 mg/kg every 24 hours. Monitoring PDA closure rate, circulatory function, renal function, blood coagulation and the incidence of intracraniaq hemorrhage were taken before and after the treatment. Result: ( 1 ) 99 patients ( 99/106, 93.4% ) got the closure of PDA. ( 2 ) The efficacy was related to the GA. The higher closure rate was in the newborns with GA 1〉 34 weeks ( 54/56, 96.4% ) than ones with GA 〈 34 weeks ( 45/50, 90% ), P〈0.05. There were no significantly differences in the closure rate between the BW≥2000 g group ( 49/52, 94.2% ) and BW 〈2000 g group ( 50/54, 92.6% ), P〉O.05. ( 3 ) Side effects manifested as a transient oliguria ( 46.2% ), creatinine and urea levels were normal. No thrombocytopenia. Feeding intolerance in preterm children was 29.2%, to a lesser extent, necrotizing enterocolitis does not appear. Aggravation of intracranial hemorrhage was not found. Conclusion: The efficacy and safety of administration of oral ibuprofen for treating PDA in preterm infants are acceptable. However, pharmacokinetics and clinical controlled trials are needed in the future in preterm infants to provt, the therapeutic effect and make the efficient regimen.
出处 《中国医学创新》 CAS 2014年第14期16-18,共3页 Medical Innovation of China
关键词 早产儿 动脉导管未闭 布洛芬 Infant Premature patent duetus arteriosus Ibuprofen
  • 相关文献

参考文献12

  • 1Ohlsson A,Walia R,Shah S.Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants[J].Cochrane Database Syst Rev,2008,23(1):CD003481.
  • 2Van Overmeire B,Smets K,Lecoutere D,et al.A comparison of ibuprofen and indomethacin for closur of patent ductus arteriosus[J].N Engl J Med,2000,343(10):674-681.
  • 3Schneider D J,Moore J W.patent ductus arteriosus[J].Circulation,2006,114(17):1873-1882.
  • 4Dani C,Bertini G,Pezzati M,et al.prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants:a multicenter,randomized study[J].Pediatrics,2005,115(6):1529-1535.
  • 5宋超,赵荣生.布洛芬治疗早产儿动脉导管未闭的临床研究进展[J].中国临床药理学杂志,2013,29(7):554-556. 被引量:12
  • 6Gokmen T,Erdeve O,Altug N,et al.Efficacy and safety of orai versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus[J].J Pediatr,2011,158(4):549-554.
  • 7van Overmeire B,Touw D,Schepens P J,et al.Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus[J].Clin Pharmacol Ther,2001,70(4):336-343.
  • 8Dani C,Vangi V,Bertini G,et al.High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants:a randomized controlled study[J].Clin Pharmacol Ther,2012,91(4):590-596.
  • 9Desfrere L,Zohar S,Morville P,et al.Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method[J].J Clin Pharm Ther,2005,30(2):121-132.
  • 10Thomas R I,Parker G C,Van Overmeire B.A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus[J].Eur J Pediatr,2005,164(3):135-140.

二级参考文献48

  • 1Ohlsson A,Walia R,Shah S.Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants [ J ].Cochrane Datebase Syst Rev,2003,(2):3481.
  • 2van Overmeire B,Smets K,Lecoutere D,et al.A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus[ J ].N Engl J Med,2000,343:674-681.
  • 3Raju NV,Bharadwaj RA,Thonas R,et al.Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia:a pilot study[J].J Perinatol,2000,1:13-16.
  • 4van Overmeire B,Touw D,Schepens PJC,et al.Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus[J ].Clin Pharmacol Ther,2001,70:336-343.
  • 5Sharma PK,Garg Sk,Narang A.Pharmacokinetics of oral ibuprofen in premature infants[ J ].J Clin Pharmacol,2003,43 (9):968-973.
  • 6Heyman E,Morag I,Batash D,et al.Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns:a pilot study[ J ].Pediatrics,2003,112 (3):354-358.
  • 7Itabashi K,Ohno T,Nishida H.Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin[ J ].J Pediatr,2003,143(2):203-207.
  • 8Thomas RL,Parker GC,van Overmeire B.A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus [J].Eur J Pediatr,2005,164(3):135-140.
  • 9Gournay V,Savagner C,Thiriez G,et al.Pulmonary hypertension after ibuprofen prophylaxis in very low preterm infants [ J ].Lancet,2002,359:1486-1488.
  • 10Wyllie J, Treatment of patent ductus arteriosus [J]. Semin Neonatol, 2003, 8(6) : 425-432.

共引文献43

同被引文献42

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部